SHATTUCK LABS INC. - COMMON STOCK

Shattuck Labs to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 11, 2021

04 Aug 2021 08:00:01 By Nasdaq GlobeNewswire

Shattuck Labs Appoints Abhinav A. Shukla as Chief Technical Officer

01 Jun 2021 10:44:16 By Nasdaq GlobeNewswire

Shattuck Labs Reports First Quarter 2021 Financial Results and Recent Business Highlights

10 May 2021 07:00:01 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming May Conferences

30 Apr 2021 17:33:52 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit

28 Apr 2021 16:45:00 By Nasdaq GlobeNewswire

Shattuck Labs Highlights Preclinical Data for SL-9258 (TIGIT-Fc-LIGHT) in an Acquired Resistance Model and Expanded Preclinical Data from the GADLEN™ Platform at AACR 2021

12 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Shattuck Labs Announces Promotion of Andrew R. Neill to Chief Financial Officer

16 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

15 Mar 2021 16:45:00 By Nasdaq GlobeNewswire

Shattuck Labs to Present Two Posters at the 2021 American Association for Cancer Research (AACR) Annual Meeting

11 Mar 2021 08:27:56 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming March Investor Conferences

23 Feb 2021 18:40:48 By Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Citi’s 2021 Virtual Immuno-Oncology Day

12 Feb 2021 09:41:04 By Nasdaq GlobeNewswire

Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference

07 Jan 2021 17:27:12 By Nasdaq GlobeNewswire

Shattuck Labs to Present at 39th Annual J.P. Morgan Healthcare Conference

06 Jan 2021 08:23:24 By Nasdaq GlobeNewswire